ArticleMolecular cancer therapeutics2025

Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab.

Dong Kwon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.